logo_artidis.png
MD Anderson and ARTIDIS Announce Strategic Alliance to Advance Nanomechanical Technology Platform for Optimizing Cancer Treatment
03 oct. 2022 09h05 HE | ARTIDIS AG
HOUSTON and BASEL, Switzerland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- ARTIDIS AG, the developer of the first nanomechanical technology platform for tissue analytics, and The University of Texas MD...
logo_1_3600px.png
Mission Cure Holdings, Path BioAnalytics and Ariel Precision Medicine, Launch Unique Research Alliance to Advance Treatments for Pancreatitis
15 juin 2020 08h00 HE | Ariel Precision Medicine
New York; Chapel Hill, NC; Pittsburgh, June 15, 2020 (GLOBE NEWSWIRE) -- Mission Cure Holdings, LLC, Path BioAnalytics, Inc. and Ariel Precision Medicine, Inc. jointly announced the creation of a...